Michael Ploug

Michael Ploug is a Professor and Group Leader at the Biotech Research & Innovation Centre (BRIC), part of the Faculty of Health and Medical Sciences at the University of Copenhagen. His research program focuses on molecular mechanisms of lipoprotein metabolism and cardiovascular biology, with significant contributions to understanding triglyceride regulation and related disorders.

Dr. Ploug's primary research interests include:

• Lipoprotein metabolism, particularly lipoprotein lipase (LPL) function and regulation
• Triglyceride metabolism and associated disorders
• Molecular mechanisms underlying cardiovascular diseases
• Cancer biology, with recent work on pancreatic cancer therapeutics
• Protein structure-function relationships in metabolic regulation

Analysis of Dr. Ploug's recent publications reveals a consistent focus on lipoprotein metabolism mechanisms, particularly the role of lipoprotein lipase in triglyceride homeostasis. His work spans from fundamental molecular mechanisms to translational applications, with significant contributions to understanding APOA5 function and developing therapeutic approaches for metabolic disorders. His research demonstrates strong international collaboration across multiple countries.

Dr. Ploug's research impact is evidenced by:

• Pickup by 6 news outlets
• 1 blog mention
• 16 posts by X users
• Reference in 1 patent
• 2 mentions by Bluesky users
• 26 readers on Mendeley

As Group Leader of the Ploug Group at BRIC, he maintains an active laboratory with significant external collaborations. His research program bridges basic science with potential clinical applications in metabolic and cardiovascular diseases.